Article
TT genotype of the MMP-9-1562C/T polymorphism may be a risk factor for thrombolytic therapy-induced hemorrhagic complications after acute ischemic stroke.
Pharmacotherapy - 1 Jul 2021
Dusanovic Pjevic Marija, Jekic Biljana, Beslac Bumbasirevic Ljiljana, Vojvodic Ljubica, Damnjanovic Tatjana, Grk Milka, Maksimovic Nela, Pesic Milica, Gulic Milica, Trickovic Jelena, Kacar Katarina
Abstract excerpt
INTRODUCTION: Levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) influence recombinant tissue plasminogen activator (rtPA) therapy response in patients with acute ischemic stroke (AIS). Serum levels of MMPs and TIMPs along with the expression of genes coding these proteins are related to the recovery and appearance of adverse effects (AE) after AIS. Consequently, it is important to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
